DR

Devendradatta Raosaheb Khodade

Active Director Director DIN 11835319
DIN 11835319 First appointment Jul 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Devendradatta Raosaheb Khodade

Devendradatta Raosaheb Khodade is a Director at Sharadaprakash Pharmaceuticals Private Limited (since 2026).

DIN 11835319
Primary Designation Director
First Appointment 17 Jul 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director17 Jul 20262026Active

Board colleagues of Devendradatta Raosaheb Khodade

Directorship timeline

Open interactive timeline →
Sharadaprakash Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Devendradatta Raosaheb Khodade

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Devendradatta Raosaheb Khodade

Devendradatta Raosaheb Khodade currently holds 1 directorship: Sharadaprakash Pharmaceuticals Private Limited (Director, since 17 Jul 2026).

Devendradatta Raosaheb Khodade was first appointed on 17 Jul 2026 as Director at Sharadaprakash Pharmaceuticals Private Limited.

The current boards of Devendradatta Raosaheb Khodade's companies include Prakash Ananda Bansode (Sharadaprakash Pharmaceuticals Private Limited), Yashasvi Prakash Bansode (Sharadaprakash Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available